首页|免疫细胞在非酒精性脂肪性肝病发病机制中的作用

免疫细胞在非酒精性脂肪性肝病发病机制中的作用

扫码查看
非酒精性脂肪性肝病(NAFLD)是最常见的慢性肝病,是从脂肪堆积到变性炎症,并出现非酒精性脂肪性肝炎(NASH),直至引发肝纤维化、肝硬化甚至肝癌的一系列过程。NAFLD目前已经是全球感染人群占比最大的肝病且发病率逐年上升。NAFLD是一种新陈代谢紊乱的疾病,但它也涉及多种免疫细胞介导的炎症过程,通过分泌促炎和/或抗炎因子来促进和/或抑制肝细胞炎症,从而影响NAFLD的进程。然而,NAFLD潜在的疾病机制及免疫细胞在其中的作用仍在研究之中,留下了许多悬而未决的问题。本综述介绍了免疫细胞在NAFLD发病和致病过程中相互作用的最新概念,重点介绍了在NAFLD中表现出具有治疗意义的免疫学特性的特定非免疫细胞,以便更好地了解表现出治疗特性的免疫/非免疫细胞的作用机制,从而在未来设计出治疗NAFLD的创新性和更具特异性的药物。
Comprehensive Understanding of Immune Cells in The Pathogenesis of Non-alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease(NAFLD)is the most common chronic liver disease,defined by several phases,ranging from benign fat accumulation to non-alcoholic steatohepatitis(NASH),which can lead to liver cancer and cirrhosis.Although NAFLD is a disease of disordered metabolism,it also involves several immune cell-mediated inflammatory processes,either promoting and/or suppressing hepatocyte inflammation through the secretion of pro-inflammatory and/or anti-inflammatory factors to influence the NAFLD process.However,the underlying disease mechanism and the role of immune cells in NAFLD are still under investigation,leaving many open-ended questions.In this review,we presented the recent concepts about the interplay of immune cells in the onset and pathogenesis of NAFLD.We also highlighted the specific non-immune cells exhibiting immunological properties of therapeutic significance in NAFLD.We hope that this review will help guide the development of future NAFLD therapeutics.

non-alcoholic fatty liver diseasemetabolically associated fatty liver disease(MAFLD)T cellsmyeloid cellsmesenchymal stem cells

欧阳飞凡、RASHEED Madiha、李博、邓玉林

展开 >

北京理工大学,珠海校区,珠海 519088

北京理工大学生命学院生物医药分离与分析北京市重点实验室,北京 100081

北京理工大学前沿交叉科学研究院,北京 100081

非酒精性脂肪性肝病 代谢相关性脂肪性肝病(MAFLD) T细胞 髓样细胞 间充质干细胞

国家自然科学基金北京理工大学科技创新计划科研基地科技专项计划资助项目

82202072

2024

生物化学与生物物理进展
中国科学院生物物理研究所,中国生物物理学会

生物化学与生物物理进展

CSTPCD北大核心
影响因子:0.476
ISSN:1000-3282
年,卷(期):2024.51(9)